OpenFilings
Calidi Biotherapeutics, Inc.
Form
8-K
Report Period
2025-11-07
Date Filed
2025-11-10
Time Filed
08:30:53
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
EX-99.1
EX-99.2
CALIDI BIOTHERAPEUTICS PRESENTS NEW DATA ON ITS THERAPEUTIC LEAD, CLD-401, AT TH
Filing on SEC Edgar